Adrenoleukodystrophy (patient information)
For the WikiDoc page for this topic, click here
Editor-in-Chief: Alexandra M. Palmer
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
What is Adrenoleukodystrophy?
Adrenoleukodystrophy describes several closely related inherited disorders that disrupt the breakdown (metabolism) of certain fats (very-long-chain fatty acids).
What are the symptoms of Adrenoleukodystrophy?
What causes Adrenoleukodystrophy?
Adrenoleukodystrophy is passed down from parents to their children as an X-linked genetic trait. It therefore affects mostly males, although some women who are carriers can have milder forms of the disease. It affects approximately 1 in 20,000 people from all races.
The condition results in the buildup of very-long-chain fatty acids in the nervous system, adrenal gland, and testes, which disrupts normal activity. There are three major categories of disease:
- Childhood cerebral form -- appears in mid-childhood (at ages 4 - 8)
- Adrenomyelopathy -- occurs in men in their 20s or later in life
- Impaired adrenal gland function (called Addison disease or Addison-like phenotype) -- adrenal gland does not produce enough steroid hormones
Who is at risk for Adrenoleukodystrophy?
How do I know I have Adrenoleukodystrophy?
When to seek urgent medical care
Treatment options
Where to find medical care for Adrenoleukodystrophy
Directions to Hospitals Treating Adrenoleukodystrophy